Fosgonimeton features a peptide-derived molecular architecture used to study receptor-associated interactions and structural adaptability. Its residues generate a balanced hydrophobic-polar environment that supports folding analysis. Researchers examine its behavior in solution to map binding equilibria. Applications include ligand-design research, peptide engineering, and biophysical characterization.
CAT No: R2347
CAS No:2093305-05-4
Synonyms/Alias:Fosgonimeton;2093305-05-4;Fosgonimeton [INN];Fosgonimeton [USAN];H91OA9858J;UNII-H91OA9858J;Fosgonimeton [USAN:INN];ATH-1017 FREE ACID;WHO 11782;L-Isoleucinamide, O-(phosphono-kappaO)-N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-,;L-Isoleucinamide, O-(phosphono-kappaO)-N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-;Fosgonimeton (USAN/INN);NDX-1017 FREE ACID;CHEMBL5095419;AKOS040757261;DA-63589;HY-132814;CS-0204081;D12392;G18373;[4-[(2S)-3-[[(2S,3S)-1-[(6-amino-6-oxohexyl)amino]-3-methyl-1-oxopentan-2-yl]amino]-2-(hexanoylamino)-3-oxopropyl]phenyl] dihydrogen phosphate;dihydrogen 4-[(2S)-3-({(2S,3S)-1-[(6-amino-6-oxohexyl)amino]-3-methyl-1-oxopentan-2-yl}amino)-2-hexanamido-3-oxopropyl]phenyl phosphate;L-ISOLEUCINAMIDE, O-(PHOSPHONO-.KAPPA.O)-N-(1-OXOHEXYL)-L-TYROSYL-N-(6-AMINO-6-OXOHEXYL)-,;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.